Know How to Manage Dyslipidemia in Patients Living With HIV

August 2019

Better antiretroviral therapy means more patients with HIV will face dyslipidemia and CV disease...instead of opportunistic infections.

HIV itself increases CV risk...possibly by triggering inflammatory mediators linked to atherosclerosis or platelet activation.

And early use of antiretrovirals is key...since uncontrolled HIV carries a higher risk of MI, stroke, heart failure, etc.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Photosensitivity Identify and Manage Med-Induced Photosensitivity
Insulin Help Patients With Skyrocketing Insulin Costs
Opioids Don't Think of Tramadol as a "Safer" Opioid
Lupus Be Familiar With Nuances for Managing Lupus
Pregnancy Weigh OTC Options for Treating GI Issues in Pregnancy
HIV & AIDS Know How to Manage Dyslipidemia in Patients Living With HIV
Diabetes Consider Cardiovascular Benefits When Choosing a GLP-1 Agonist
Antimalarials Add Arakoda to Your List of Malaria Prophylaxis Options
Liver Disease Maximize Safety When Using Anticoagulants in Patients With Cirrhosis
Patient Safety Tell Patients to Avoid Unsafe Stem Cells